share_log

Credit Suisse Group Lowers Axon Enterprise (NASDAQ:AXON) Price Target to $134.00

Credit Suisse Group Lowers Axon Enterprise (NASDAQ:AXON) Price Target to $134.00

瑞士信貸集團將Axon Enterprise(納斯達克:AXON)目標價下調至134.00美元
Financial News Live ·  2022/07/16 17:01

Axon Enterprise (NASDAQ:AXON – Get Rating) had its target price cut by stock analysts at Credit Suisse Group from $169.00 to $134.00 in a research note issued on Thursday, The Fly reports. Credit Suisse Group's price target would indicate a potential upside of 41.57% from the stock's previous close.

據The Fly報道,在週四發佈的一份研究報告中,瑞士信貸集團的股票分析師將Axon Enterprise(納斯達克:AXON-GET評級)的目標價從169.00美元下調至134.00美元。瑞士信貸集團的目標價將顯示該股較前一交易日收盤價有41.57%的潛在上行空間。

Several other equities analysts have also weighed in on AXON. Northland Securities reduced their price objective on shares of Axon Enterprise from $180.00 to $130.00 in a research report on Thursday, May 12th. Robert W. Baird reduced their price objective on shares of Axon Enterprise from $145.00 to $125.00 in a research report on Wednesday, May 11th. StockNews.com raised shares of Axon Enterprise from a "hold" rating to a "buy" rating in a research note on Saturday, June 18th. Morgan Stanley lowered shares of Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 price objective for the company. in a research note on Monday, May 23rd. Finally, JMP Securities reaffirmed a "buy" rating and set a $195.00 price objective on shares of Axon Enterprise in a research note on Wednesday, June 1st. One analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of "Buy" and a consensus price target of $169.00.

其他幾位股票分析師也加入了Axon的行列。Northland Securities在5月12日星期四的一份研究報告中將Axon Enterprise的股票目標價從180.00美元下調至130.00美元。羅伯特·W·貝爾德在5月11日星期三的一份研究報告中將Axon Enterprise的股票目標價從145.00美元下調至125.00美元。在6月18日星期六的一份研究報告中,StockNews.com將Axon Enterprise的股票評級從持有上調至買入。摩根士丹利將Axon Enterprise的股票評級從增持下調至持平,併為該公司設定了120.00美元的目標價。在5月23日星期一的一份研究報告中。最後,JMP證券在6月1日星期三的一份研究報告中重申了“買入”評級,併為Axon Enterprise的股票設定了195.00美元的目標價。一位分析師對該股的評級為持有,8位分析師給出了買入評級,一位分析師給出了強烈的買入評級。根據MarketBeat.com的數據,Axon Enterprise的平均評級為買入,共識目標價為169.00美元。

Get
到達
Axon Enterprise
Axon企業
alerts:
警報:

Axon Enterprise Stock Performance

Axon企業股票表現

Shares of AXON opened at $94.65 on Thursday. Axon Enterprise has a 52-week low of $82.49 and a 52-week high of $209.00. The company has a quick ratio of 2.18, a current ratio of 2.43 and a debt-to-equity ratio of 0.02. The firm has a 50-day moving average price of $94.58 and a 200 day moving average price of $116.57. The firm has a market capitalization of $6.72 billion, a PE ratio of 182.02 and a beta of 0.61.

Axon的股票週四開盤報94.65美元。Axon Enterprise的52周低點為82.49美元,52周高位為209.00美元。該公司的速動比率為2.18,流動比率為2.43,債務權益比為0.02。該公司的50日移動均線價格為94.58美元,200日移動均線價格為116.57美元。該公司的市值為67.2億美元,市盈率為182.02,貝塔係數為0.61.

Axon Enterprise (NASDAQ:AXON – Get Rating) last posted its quarterly earnings data on Tuesday, May 10th. The biotechnology company reported $0.76 earnings per share for the quarter. Axon Enterprise had a net margin of 4.62% and a return on equity of 3.90%. The company had revenue of $256.43 million during the quarter, compared to analyst estimates of $233.57 million. During the same quarter last year, the firm posted ($0.75) EPS. The business's revenue for the quarter was up 31.5% on a year-over-year basis. On average, sell-side analysts anticipate that Axon Enterprise will post 1.35 earnings per share for the current fiscal year.
Axon Enterprise(納斯達克代碼:Axon-Get Rating)最近一次公佈季度收益數據是在5月10日(星期二)。這家生物技術公司公佈本季度每股收益為0.76美元。Axon Enterprise的淨利潤率為4.62%,股本回報率為3.90%。該公司本季度營收為2.5643億美元,而分析師預期為2.3357億美元。去年同期,該公司公佈的每股收益為0.75美元。該業務當季營收較上年同期增長31.5%。賣方分析師平均預計Axon Enterprise本財年每股收益將達到1.35美元。

Insider Transactions at Axon Enterprise

Axon Enterprise的內幕交易

In other news, Director Mark W. Kroll sold 3,159 shares of the stock in a transaction that occurred on Wednesday, June 8th. The shares were sold at an average price of $102.82, for a total value of $324,808.38. Following the completion of the sale, the director now directly owns 13,691 shares of the company's stock, valued at $1,407,708.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 6.90% of the stock is owned by insiders.

在其他新聞方面,董事馬克·克羅爾在6月8日星期三的一筆交易中出售了3159股該公司股票。這些股票的平均價格為102.82美元,總價值為324,808.38美元。出售完成後,董事現在直接擁有該公司13,691股股票,價值1,407,708.62美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過美國證券交易委員會網站獲得。6.90%的股份由內部人士持有。

Institutional Trading of Axon Enterprise

Axon企業的制度性交易

A number of hedge funds have recently made changes to their positions in the stock. Nisa Investment Advisors LLC lifted its position in shares of Axon Enterprise by 25.3% in the fourth quarter. Nisa Investment Advisors LLC now owns 495 shares of the biotechnology company's stock worth $69,000 after purchasing an additional 100 shares in the last quarter. Advisor Group Holdings Inc. raised its position in Axon Enterprise by 0.6% during the fourth quarter. Advisor Group Holdings Inc. now owns 17,989 shares of the biotechnology company's stock valued at $2,823,000 after acquiring an additional 100 shares in the last quarter. GM Advisory Group Inc. raised its position in Axon Enterprise by 3.2% during the fourth quarter. GM Advisory Group Inc. now owns 3,266 shares of the biotechnology company's stock valued at $513,000 after acquiring an additional 101 shares in the last quarter. State of Alaska Department of Revenue raised its position in Axon Enterprise by 1.3% during the first quarter. State of Alaska Department of Revenue now owns 9,636 shares of the biotechnology company's stock valued at $1,327,000 after acquiring an additional 120 shares in the last quarter. Finally, Stratos Wealth Partners LTD. raised its position in Axon Enterprise by 2.8% during the first quarter. Stratos Wealth Partners LTD. now owns 4,663 shares of the biotechnology company's stock valued at $642,000 after acquiring an additional 125 shares in the last quarter. 72.06% of the stock is owned by hedge funds and other institutional investors.

一些對衝基金最近改變了他們在該股的頭寸。NISA Investment Advisors LLC在第四季度將其在Axon Enterprise的股票頭寸提高了25.3%。NISA Investment Advisors LLC現在持有這家生物技術公司495股股票,價值6.9萬美元,上個季度又購買了100股。Advisor Group Holdings Inc.在第四季度將其在Axon Enterprise的頭寸提高了0.6%。Advisor Group Holdings Inc.現在持有這家生物技術公司17,989股股票,價值2,823,000美元,上個季度又收購了100股。通用汽車諮詢集團(GM Consulting Group Inc.)第四季度將其在Axon Enterprise的持倉提高了3.2%。通用汽車諮詢集團(GM Consulting Group Inc.)在上個季度增持了101股後,目前持有這家生物技術公司3,266股股票,價值513,000美元。阿拉斯加州税務局在第一季度將其在Axon Enterprise的頭寸提高了1.3%。阿拉斯加州税務局在上個季度增持了120股後,現在持有這家生物技術公司9636股股票,價值132.7萬美元。最後,Stratos Wealth Partners Ltd.在第一季度將其在Axon Enterprise的頭寸提高了2.8%。Stratos Wealth Partners Ltd.在上個季度又收購了125股後,現在擁有4663股這家生物技術公司的股票,價值64.2萬美元。72.06%的股票由對衝基金和其他機構投資者持有。

Axon Enterprise Company Profile

Axon企業公司簡介

(Get Rating)

(獲取評級)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Axon Enterprise,Inc.在美國和國際上以泰瑟品牌開發、製造和銷售導電能源設備(CED)。它通過兩個部分運作,泰瑟槍和軟件和傳感器。該公司還提供硬件和基於雲的軟件解決方案,使執法部門能夠捕獲、安全存儲、管理、共享和分析視頻和其他數字證據。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
  • MarketBeat: Week in Review 7/11 – 7/15
  • Is Coupang's Stock On The Verge Of A Turnaround?
  • Should You Have These Two Banks In Your Portfolio?
  • Verint Systems Stock is a Customer Engagement Play
  • Why Shopify Stock Split...And is as Shoppable as Ever
  • 免費獲取StockNews.com關於Axon Enterprise(Axon)的研究報告
  • MarketBeat:回顧一週7/11-7/15
  • Coupang的股票即將翻身嗎?
  • 你的投資組合中應該有這兩家銀行嗎?
  • Verint Systems Stock是一場客户互動活動
  • 為什麼Shopify股票拆分...並一如既往地適合購物

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.

接受Axon企業日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收Axon Enterprise和相關公司的最新新聞和分析師評級的每日簡明摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論